birb 796 has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunliffe, V; Frearson, J; Fujino, A; Gordon, R; Harris, CJ; Imai, M; Imaizumi, K; Kalloo-Hosein, H; Kambe, M; Kataoka, K; Kobayashi, S; Komatsu, K; Kosugi, T; Le, J; Makino, H; Matsueda, Y; Mitchell, DR; Oue, Y; Patel, G; Sakai, Y; Sherborne, B; Simpson, DJ; Sugiura, S; Suzuki, N; Takenouchi, O; Takimoto-Kamimura, M; Thomas, PS; Unoki, G; Yamakoshi, Y | 1 |
1 other study(ies) available for birb 796 and Shock, Septic
Article | Year |
---|---|
Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approach.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Crystallography, X-Ray; HSP27 Heat-Shock Proteins; Humans; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Phosphorylation; Protein Conformation; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Shock, Septic; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2012 |